Trial Profile
Lenalidomide and warfarin; a pharmacokinetic study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Warfarin (Primary)
- Indications Haematological malignancies; Multiple myeloma
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Celgene Corporation
- 17 Nov 2015 New trial record